+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone



Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone



Cureus 9(12): E1934



Introduction The roles of early whole brain radiotherapy (WBRT) and upfront stereotactic radiosurgery (SRS) alone in the treatment of melanoma patients with brain metastasis remain uncertain. We investigated the volumetric kinetics of brain metastasis development and associations with clinical outcomes for melanoma patients who received upfront SRS alone. Methods Volumetric brain metastasis velocity (vBMV) was defined as the volume of new intracranial disease at the time of distant brain failure (DBF) for the first DBF (DBF1) and second DBF (DBF2) averaged over the time since initial or most recent SRS. Non-volumetric brain metastasis velocity (BMV) was calculated for comparison. Results Median overall survival (OS) for all patients was 7.7 months. Increasing vBMVDBF1 was associated with worsened OS (hazard ratio (HR): 1.10, confidence interval (CI): 1.02 - 1.18, p = .01). Non-volumetric BMVDBF1 was not predictive of OS after DBF1 (HR: 1.00, CI: 0.97 - 1.02, p = .77). Cumulative incidence of DBF2 at three months after DBF1 was 50.0% for vBMVDBF1 > 4 cc/yr versus (vs) 15.1% for vBMVDBF1 ≤ 4 cc/yr, (Gray's p-value = .02). Cumulative incidence of salvage WBRT at three months after DBF1 was 50.0% for vBMVDBF1 > 4 cc/yr vs 2.3% for vBMVDBF1 ≤ 4 cc/yr (Gray's p-value < .001). Conclusion In melanoma patients with brain metastasis, volumetric BMV was predictive of survival, shorter time to second DBF, and the need for salvage WBRT. Non-volumetric BMV, however, did not predict for these outcomes, suggesting that vBMV is a stronger predictor in melanoma.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 065549812

Download citation: RISBibTeXText

PMID: 29464141


Related references

Survival and Failure Outcomes Predicted By Brain Metastasis Kinetics Following Initial Distant Brain Failure in Melanoma Patients Treated Upfront with Stereotactic Radiosurgery Alone. International Journal of Radiation Oncology*biology*physics 99(2): E86-E87, 2017

Improved Survival Following Immunotherapy in Patients with Lung and Melanoma Primaries Metastatic to the Brain Treated with Upfront Stereotactic Radiosurgery. International Journal of Radiation Oncology*Biology*Physics 102(3): S140-S141, 2018

Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies. European Journal of Cancer 75: 169-178, 2017

Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain Metastases. Neurosurgery 2018, 2018

Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone. International Journal of Radiation Oncology, Biology, Physics 98(1): 131-141, 2017

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. Neuro-Oncology 19(4): 558-566, 2016

Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With Greater Than 4 Brain Metastases. International Journal of Radiation Oncology*biology*physics 99(2): E80-E81, 2017

Cmet-41. Overall Survival Of Melanoma Brain Metastasis Patient Cohorts Treated With Stereotactic Radiosurgery With Or Without Immunotherapy. Neuro-Oncology 19(Suppl_6): vi48, 2017

Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases. Journal of Neuro-Oncology 132(3): 455-462, 2017

Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases. Clinical Oncology ) 29(10): E157-E164, 2017

Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. Acta Ophthalmologica Scandinavica 81(4): 383-388, 2003

Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. Journal of Neurosurgery 97(5 Suppl.): 499-506, 2003

SU-E-T-645: Treatment of Multiple Brain Metastases Using Stereotactic Radiosurgery with Single-Isocenter Volumetric Modulated Arc Therapy: Comparison with Conventional Dynamic Conformal Arc and Static Beam Stereotactic Radiosurgery. Medical Physics 39(6part20): 3854, 2012

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?. Lung Cancer 68(2): 258-263, 2010

Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. European Journal of Cancer 84: 44-54, 2017